Table 1.
p62/SQSTM1 | ||||
---|---|---|---|---|
|
||||
Parameters | No. of cases | Negative | Positive | p-values |
Age at diagnosis | ||||
≤ 65 years | 27 | 8 | 19 | 0.7613 |
> 65 years | 27 | 7 | 20 | |
Gender | ||||
Male | 47 | 14 | 33 | 0.6586 |
Female | 7 | 1 | 6 | |
Stage: TNM class | ||||
≤ II | 10 | 4 | 6 | 0.4376 |
≥ III | 44 | 11 | 33 | |
T classification | ||||
≤ T2 | 24 | 7 | 17 | 0.8385 |
≥ T3 | 30 | 8 | 22 | |
Nodes status | ||||
Negative | 18 | 4 | 14 | 0.5192 |
Positive | 36 | 11 | 25 | |
Treatment | ||||
Surgery: S | 22 | 6 | 16 | 0.9452 |
Radiation: R | 32 | 9 | 23 | |
Differentiation | ||||
Well and moderately | 27 | 7 | 20 | 0.7613 |
Poorly | 27 | 8 | 19 | |
Ki67 | ||||
≤ 40% | 30 | 8 | 22 | 0.8385 |
> 40% | 24 | 7 | 17 | |
Nrf2 | ||||
Negative | 25 | 10 | 15 | 0.0626 |
Positive | 29 | 5 | 24 |
Chi-square and Fisher’s exact tests were used to evaluate the relationship between clinicopathological parameters and p62 expression.